TOP TIERMARKET NEWSWIRE
SEC Form 4 history

SYNDAX PHARMACEUTICA (SNDX) insider trades

SYNDAX PHARMACEUTICA (SNDX) insider trading activity (SEC Form 4). Over the trailing 90 days, SNDX insiders filed 0 purchases totalling $0 and 4 sales totalling $2.1M — net SELLING of $2.1M. Most recent filing: Jul 9, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
4
$2.1M
Net (90d)
-$2.1M
net selling
Most recent
Jul 9, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Jul 9, 2026Metzger Michael ACEOS SaleOE—$24.24$785Kfiling
Jun 12, 2026Botwood Nicholas A.J.Head of R, D, CMOS SaleOE—$18.07$1.2Mfiling
Jun 2, 2026Metzger Michael ACEOS Sale—$18.99$130Kfiling
Jun 2, 2026Goldan Keith A.CFOS Sale—$18.99$22Kfiling